General contact

Head Office
Novartis International AG
CH-4002 Basel
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)

Investors

Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland

+41 61 324 79 44

Media

Global Oncology Media Relations
Denise Brashear
Novartis Oncology Global Public Relations

+1 862 778 7336

Novartis Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

pane 4 content

This site is not intended for U.S. residents.

Oncology Personalized Medicine: Global Patient Group Survey

Navigating the System

Navigating the healthcare system will be a significant challenge in facilitating patient access to PM. New relationships and collaboration among multiple disciplines are required for successful implementation of PM.

Practical Implementation Is a Challenge

Patient groups surveyed identify two significant hurdles to the success of personalized medicine: navigating the healthcare system to help patients gain access to treatment and lack of accurate information

Practical Implementation Is a Challenge

Organizations Must Form & Strengthen Relationships with HCPs

Respondents agree that personalized medicine will require their organizations to form or strengthen relationships with healthcare professionals

Organizations Must Form & Strengthen Relationships with HCPs

Organizations Must Form & Strengthen Relationships Beyond HCPs

Nearly half of respondents agree that personalized medicine will require their organizations to form or strengthen relationships with new stakeholders [beyond doctors]

Organizations Must Form & Strengthen Relationships Beyond HCPs

Need for Multidisciplinary Collaboration

Over half of respondents agree that successful implementation of personalized medicine will require collaboration among multiple disciplines, including payers, clinicians, ancillary care, and pathologists

Need for Multidisciplinary Collaboration